Dosimetry & toxicity comparison between CBCT-Guided and MR-Guided Prostate Ultra-hypofractionated RT

被引：0
|
作者：
Kong, V. [1 ]
Padayachee, J. [1 ]
Dang, J. [1 ]
Li, W. [1 ]
Malkov, V. [1 ]
Winter, J. [1 ]
Navarro, I. [1 ]
Berlin, A. [1 ]
Helou, J. [1 ]
Raman, S. [1 ]
Chung, P. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0952
引用
收藏
页码：S844 / S845
页数：2
相关论文
共 50 条
  • [21] MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
    Cuccia, Francesco
    Corradini, Stefanie
    Mazzola, Rosario
    Spiazzi, Luigi
    Rigo, Michele
    Bonu, Marco Lorenzo
    Ruggieri, Ruggero
    Bastia, Michela Buglione di Monale e
    Magrini, Stefano Maria
    Alongi, Filippo
    CANCERS, 2021, 13 (08)
  • [22] MR-guided SBRT in Synchronous Oligometastatic Prostate Cancer: Toxicity and Preliminary Outcomes
    Poon, Darren M. C.
    Yuan, Jing
    Wong, Oi Lei
    Yang, Bin
    Chiu, Sin Ting
    Chiu, George
    Cheung, Kin Yin
    Yu, Siu Ki
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2365 - S2367
  • [23] Acute toxicity of MR-guided radiotherapy for prostate cancer at the 1.5 T MR-linac
    Moller, P. K.
    Gornitzka, J.
    Bernchou, U.
    Dysager, L.
    Bertelsen, A. S.
    Nyborg, C. J.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S401 - S402
  • [24] A TOXICITY COMPARISON OF STEREOTACTIC BODY RADIOTHERAPY IN LOCALIZED PROSTATE CANCER: 1.5T MR-GUIDED RT VERSUS LINAC- BASED VMAT
    Trapani, Giovanna
    Nicosia, Luca
    Vitale, Claudio
    Cuccia, Francesco
    Rigo, Michele
    Figlia, Vanessa
    Mazzola, Rosario
    Giaj-Levra, Niccolo
    Ricchetti, Francesco
    Ruggeri, Ruggiero
    Alongi, Filippo
    ANTICANCER RESEARCH, 2022, 42 (10) : 5129 - 5130
  • [25] MR-guided prostate brachytherapy in a low-field open MR system: canine and in vitro dosimetry study
    Antal, G.
    Lakosi, F.
    Vandulek, C. S.
    Garamvolgyi, R.
    Petnehazy, O.
    Kovacs, A.
    Hadjiev, J.
    Bogner, R.
    Repa, I.
    EJC SUPPLEMENTS, 2007, 5 (04): : 284 - 284
  • [26] Comparison of prostate delineation on multi-modality imaging for MR-guided radiotherapy
    Pathmanathan, A.
    Schmidt, M.
    Brand, D.
    Delacroix, L.
    Eccles, C.
    Gordon, A.
    Herbert, T.
    McNair, H.
    Van As, N.
    Huddart, R.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S868 - S869
  • [27] Acute toxicity reported by patients with prostate cancer receiving online MR-guided radiotherapy
    Moller, P. K.
    Dysager, L.
    Bernchou, U.
    Bertelsen, A. S.
    Brink, C.
    Mahmood, F.
    Jensen, H. R.
    Hansen, O.
    Nyborg, C. J.
    Pappot, H.
    Dieperink, K. B.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S112 - S113
  • [28] Stereotactic adaptive MR-guided RT: post-operative RT and re-irradiation for prostate local relapse
    Castelluccia, A.
    Grimaldi, G.
    Marchesano, D.
    Annessi, I.
    Bianciardi, F.
    Dipalma, A.
    Borrazzo, C.
    Rago, M.
    Masi, M.
    El Gawary, R.
    Valentino, M.
    Verna, L.
    Gentile, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1235 - S1236
  • [29] Simulation-free treatment planning for online adaptive MR-guided RT in prostate cancer patients
    Warda, Cora
    Gani, Cihan
    Niyazi, Maximilian
    Thorwarth, Daniela
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S3651 - S3655
  • [30] Is it possible to deliver on-line MR-guided RT for prostate cancer within a feasible time frame?
    Schytte, T.
    Moller, P. K.
    Bernchou, U.
    Gottlieb, K. L.
    Lorenzen, E. L.
    Agergaard, S.
    Jensen, H. R.
    Nyborg, C. J.
    Dysager, L.
    Hansen, O.
    Mahmood, F.
    Bahij, R.
    Brink, C.
    Bertelsen, A. S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1204 - S1205
12345